# Nerlynx (neratinib maleate) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/neratinib

> The FDA approved Nerlynx (neratinib maleate), sponsored by PUMA BIOTECHNOLOGY, INC. (PBYI), on July 17, 2017.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | Nerlynx (neratinib maleate) |
| Codes |  |
| Sponsor | PUMA BIOTECHNOLOGY, INC. (PBYI) https://sec-api.dev/companies/pbyi/catalysts |
| Indications |  |
| Modality |  |
| FDA designations | none disclosed |

## Timeline

### July 17, 2017: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA208051 ORIG-1 (Type 1 - New Molecular Entity): submission_status AP, submission_status_date 20170717, review_priority STANDARD; sponsor_name PUMA BIOTECH; product NERLYNX (NERATINIB MALEATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208051%22

### February 25, 2020: label expansion decision

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA208051 SUPPL-5 (Efficacy): submission_status AP, submission_status_date 20200225, review_priority STANDARD; sponsor_name PUMA BIOTECH; product NERLYNX (NERATINIB MALEATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208051%22
- openFDA Drugs@FDA: "NDA208051 SUPPL-6 (Efficacy): submission_status AP, submission_status_date 20200225, review_priority STANDARD; sponsor_name PUMA BIOTECH; product NERLYNX (NERATINIB MALEATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208051%22

### July 29, 2020: label expansion decision

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA208051 SUPPL-7 (Efficacy): submission_status AP, submission_status_date 20200729, review_priority STANDARD; sponsor_name PUMA BIOTECH; product NERLYNX (NERATINIB MALEATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208051%22

### June 28, 2021: label expansion decision

- Status: completed, approved. Date confidence: exact.
- First seen 2026-11-12T03:44:55.771Z, last confirmed 2026-11-16T22:20:01.192Z.
- openFDA Drugs@FDA: "NDA208051 SUPPL-9 (Efficacy): submission_status AP, submission_status_date 20210628, review_priority STANDARD; sponsor_name PUMA BIOTECH; product NERLYNX (NERATINIB MALEATE)." https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA208051%22

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/neratinib.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Nerlynx (neratinib maleate) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/neratinib

```bibtex
@misc{secapidev_pdufa_neratinib_20261116,
  title        = {Nerlynx (neratinib maleate) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/neratinib}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_neratinib_20261116","title":"Nerlynx (neratinib maleate) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/neratinib","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
